Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Current Molecular Medicine
|
April 16, 2014
Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls
V Hofman, M Ilie, E Long, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
P Hofman, M Ilie, V Hofman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 19, 2019
Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma
C Bence, V Hofman, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2015
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies
M Ilie, E Long-Mira, C Bence, et al.
Cell Death and Differentiation
|
October 2, 2010
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
M-P Puisségur, N M Mazure, T Bertero, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
January 8, 2011
Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
V Hofman, E Long, M Ilie, et al.
Annales De Pathologie
|
March 18, 2014
[The French mesothelioma network from 1998 to 2013]
Françoise Galateau-Sallé, A Gilg Soit Ilg, N Le Stang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 4, 2018
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center
F Galateau Salle, N Le Stang, A G Nicholson, et al.
ESMO Open
|
June 15, 2024
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
É Mathian, Y Drouet, A Sexton-Oates, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Current Molecular Medicine
|
April 16, 2014
Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls
V Hofman, M Ilie, E Long, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
P Hofman, M Ilie, V Hofman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 19, 2019
Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma
C Bence, V Hofman, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2015
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies
M Ilie, E Long-Mira, C Bence, et al.
Cell Death and Differentiation
|
October 2, 2010
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
M-P Puisségur, N M Mazure, T Bertero, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
January 8, 2011
Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
V Hofman, E Long, M Ilie, et al.
Annales De Pathologie
|
March 18, 2014
[The French mesothelioma network from 1998 to 2013]
Françoise Galateau-Sallé, A Gilg Soit Ilg, N Le Stang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 4, 2018
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center
F Galateau Salle, N Le Stang, A G Nicholson, et al.
ESMO Open
|
June 15, 2024
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
É Mathian, Y Drouet, A Sexton-Oates, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
Page
of 6